Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Expert Review of Hematology|November 25, 2010
The impact of lymphoma and treatment on male fertilityHouchingue Eghbali, Aline Papaxanthos-RocheBulletin Du Cancer|February 16, 2002
[Update on lymphomas]Houchingue Eghbali, Pierre Soubeyran, Isabelle Soubeyran, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 26, 2012
The Caregivers Quality of Life Cancer index scale (CQoLC): an exploratory factor analysis for validation in French cancer patients' spousesAnaïs Lafaye, Stéphanie De Chalvron, Nadine Houédé, et al.Leukemia & Lymphoma|May 13, 2006
Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcomeElizabeth Fabre-Guillevin, Reza Tabrizi, Valérie Coulon, et al.European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Fludarabine phosphate-CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: a dose-finding studyPierre Soubeyran, Alain Monnereau, Houchingue Eghbali, et al.European Journal of Haematology|October 15, 2010
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)Igor Aurer, Houchingue Eghbali, John Raemaekers, et al.Critical Reviews in Oncology/Hematology|September 25, 2002
Quality of life in patients with aggressive non-Hodgkin's lymphoma. Validation of the medical outcomes study short form 20 and the Rotterdam symptom checklist in older patientsNadine Tchen, Pierre Soubeyran, Houchingue Eghbali, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphomaAnton Hagenbeek, Houchingue Eghbali, Silvio Monfardini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2007
Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'AdulteMarleen A E van der Kaaij, Natacha Heutte, Nolwenn Le Stang, et al.British Journal of Haematology|August 20, 2008
High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemiaBruno Cazin, Marine Divine, Stéphane Leprêtre, et al.Pageof 3